PatientsVille.com Logo

Pains and Metronidazole

PatientsVille

Pains Symptoms and Causes

If you've ever groaned, "Oh, my aching back!", you are not alone. Back pain is one of the most common medical problems, affecting 8 out of 10 people at some point during their lives. Back pain can range from a dull, constant ache to a sudden, sharp pain. Acute back pain comes on suddenly and usually lasts from a few days to a few weeks. Back pain is called chronic if it lasts for more than three months.

Most back pain goes away on its own, though it may take awhile. Taking over-the-counter pain relievers and resting can help. However, staying in bed for more than 1 or 2 days can make it worse.

If your back pain is severe or doesn't improve after three days, you should call your health care provider. You should also get medical attention if you have back pain following an injury.

Treatment for back pain depends on what kind of pain you have, and what is causing it. It may include hot or cold packs, exercise, medicines, injections, complementary treatments, and sometimes surgery.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Check out the latest treatments for Pains

Pains treatment research studies

Metronidazole clinical trials, surveys and public health registries


Find Drug Side Effect reports



Metronidazole Side Effects

Dysarthria (124)
Dizziness (124)
Vomiting (119)
Nausea (108)
Encephalopathy (106)
Diarrhoea (102)
Paraesthesia (93)
Headache (88)
Confusional State (80)
Ataxia (80)
Toxic Encephalopathy (71)
Pruritus (67)
Gait Disturbance (62)
Neuropathy Peripheral (60)
Pain (60)
Pyrexia (58)
Cerebellar Syndrome (58)
Rash (56)
Urticaria (51)
Malaise (49)
Neurotoxicity (44)
Anaphylactic Reaction (44)
Abdominal Pain (43)
Dyspnoea (42)
Anxiety (41)
Dysgeusia (41)
International Normalised Ratio Increased (39)
Asthenia (38)
Hypoaesthesia (37)
Fatigue (37)
Convulsion (34)
Somnolence (34)
Nuclear Magnetic Resonance Imaging Brain Abnormal (32)
Pain In Extremity (31)
Coordination Abnormal (31)
Arthralgia (31)
Abdominal Pain Upper (30)
Balance Disorder (30)
Clostridium Difficile Colitis (30)
Depression (30)
Chest Pain (30)
Cerebellar Ataxia (29)
Insomnia (28)
Dysphagia (27)
Condition Aggravated (27)
Feeling Abnormal (27)
Psychotic Disorder (27)
Nystagmus (26)
Liver Function Test Abnormal (26)
Muscular Weakness (25)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<b>Describe Your Metronidazole Experience Here:</b> after taking a total of 4 pills, 1 first day 2 second day and 1 in third day. I had symptoms begin on that second day. There was tingling in my lips with burning in my lips and tongue. T

Can I take Flagyl for a UTI?

Dentist gave me 400mg of metronidazole for toothache i feel sick and dizzy i keep going hot and cold and my skin goes red

Diagnosed with BV and started taking Flagyl orally twice per day for 7 days. In the 4th day of my treatment my period started. Had very heavy flow. No cramps but very heavy menstrual bleeding and passed large blood clots

Diahorrea, metallic taste in the mouth, burning vagina feeling sick bad stomach

Experienced palpitation

Hi just been discharged from A&amp;E. Meronidazeole 400mg. I had severe racing heart beats (resting pulse normally 53 became 90-100! and would go to 140 with no prompting). Blood pressure usually 120/60 became 135/90&gt;. Breathing was di

Hi,am 21 years old from phil. am engaging sex so many times for ten guys,time came that am discharging something unpleasant and yellow in color am shy to check a doctor so i just try to search some knowledge on net then am trying using metronidazole

I am a 18 yr old, i was pescribed metro for a infection.... 2 days into i was feeling very paranoid and frightened, last night i experienced two encounters of wide awake, shaking, grunting, crying and coldness. scareyyy :'(

I am deeply indebted to Danny Smith with his comments about metronidazole. I was also prescribed metronidazole for a tooth complaint and after experiencing dizziness and being very unwell with nausea, happened to find his remarks on the net. A

After the second day taking Lekoklar XL chest pains started and have not let up (I am on 4th day of medication). My cough has gotten better but temperature is still up and am feeling weaker now than ever.

I have been prescribed Methicol Mecobalamin 500mg twice a day for a condition diagnosed as forzen shoulder with off-and -on pains to be taken for a month. What could be the side effects of this medication.

Intersting on the Bicor . i have been on it since march this year , starting with 2.5 , then to 5.0 , 7.5 and 10mg for the last 3 months . always felt tired in the increse dosage as advised . but now have had a fe w joint aches , chest pains and cur

&lt;b&gt;Describe Your Metaxalone Experience Here:&lt;/b&gt; I took it for the firt night last night hoping that it would help my shoulder and knee pains and help me sleep and it had the opposite effect. I feel asleep fast but 2 hour

day 24 on champix tummy pains now and again,very restless sleep and strange dreams, feel sick now and again and for the most part very calm until somebody presses my buttons!!! ask my son he wanted to know if i was on steriods!!!!Big plus n

I AM 35 YEARS AND ON AN PERIMONOPAUSE AND JUST STARTED ACTIVELLE A FEW WEEKS AGO .I THEN STARTED HAVING SEVERE ABDOMINAL PAINS LIKE MENSTUAL PAIN AND DON'T KNOW WHETHER TO STOP OR CONTINUE.

<b>YES I EXPERIENCIED GEN. MUSCUAR &amp; joints pains</b>

Since taking Livalo, I have experienced; severe earaches where it was painful to swallow, headache, extreme backand stomach pains that made it very hard for me to work.&nb

I have been taking Ezetrol for 6 months without any side effects but now i have developed muscle pain in my right leg and my skin is very itchy. I have also reported pains in the stomach and under my right side ribs but she said

I'm taking Salazopyrin EN 500mg (2 tablets in the morning and 2 in the evening) for the treatment of ulcerative colitis. I have experienced unexplained high fever, aches and pains in my neck, pain behind my eyes and I'm feeling nauseou

Pains Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Literacy-Adapted Psychosocial Treatments for Chronic Pain --- "Learning About Mastering/My Pain"
Conditions: Chronic Pain;   Pain;   Widespread Chronic Pain;   Chronic Pain Syndrome;   Chronic Pain Due to Injury
Interventions: Behavioral: Pain Ed;   Behavioral: CBT for Pain;   Other: Usual Care
Outcome Measures: Brief Pain Inventory-Intensity (BPI-Intensity);   Brief Pain Inventory-Interference (BPI-Interference);   Patient Health Questionnaire - 9 (PHQ-9);   Patient Global Impression of Change (PGIC)
2 Recruiting Neck Exercises, Training and Pain Management as a Treatment for Whiplash Patients With Chronic Neck Pain
Conditions: Neck Pain;   Chronic Pain Syndrome
Interventions: Other: Education and training;   Behavioral: Pain management
Outcome Measures: Medical Outcomes Study Short Form 36 (SF36) - Physical Component Summary (PCS);   craniocervical flexion test;   cervical range of motion;   neck positioning test;   Self-rated measure Global Perceived Effect;   Neck Disability Index;   Pain Bothersomeness;   Pain Specific Functioning Scale;   TAMPA scale of Kinesiophobia;   Impact of Event scale;   Euroqol-5D;   Mechanical allodynia
3 Recruiting Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor
Condition: Chest Pain
Interventions: Procedure: Chest drain withdrawal;   Device: Pain Monitor
Outcome Measures: Pain monitor evaluation of pain;   Pain intensity
4 Recruiting Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)
Condition: Pilon Fracture
Interventions: Drug: NSAID;   Drug: Gabapentinoids;   Drug: placebo
Outcome Measures: Opioid Utilization;   Persistent Pain;   Surgery for non-union;   Post Surgical Pain Intensity;   Pre Surgical Pain Intensity;   Length of Index Hospitalization;   Adverse Effects and Complications;   Functional Outcome;   Generic Health Status;   Depressive Symptoms;   Post Traumatic Stress (PTSD);   Medical Costs;   Fracture Severity;   Fracture Classification
5 Not yet recruiting Effective Screening for Pain Study
Conditions: Pain;   Pain Management
Interventions: Behavioral: NRS pain now;   Behavioral: PEG
Outcome Measures: Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise difference scores in baseline and pain disability detection at one week, and satisfaction with pain management at one week;   Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise differences in pain missingness and rating variability;   Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise difference scores in baseline and pain disability detection at one week,
6 Recruiting The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain
Conditions: Breast Cancer;   Painful Neuropathy;   Chronic Pain;   Worries; Pain or Disability;   Quality of Life
Intervention: Behavioral: Mindfulness-Based Stress Reduction
Outcome Measures: Change from baseline in pain-related disability, as measured by the Brief Pain Inventory - Pain Interference scale, at 3-month post-intervention.;   Change from baseline in neuropathic pain intensity, as measured by the Neuropathic Pain Symptom Inventory, at 3 months post-intervention;   Change from baseline in pain severity, as measured by the Brief Pain Inventory - Pain Severity scale, at 3 months post-intervention;   Change from baseline in mood states, as measured by the Profile of Mood States scale, at 3 months post-intervention;   Overall change in status from baseline, as measured by Patient Global Impression of Change scale, at 3 months post-intervention;   Change from baseline in stress, as measured by the Perceived Stress Scale, at 3 months post-intervention;   Change from baseline in depressive symptoms, as measured by the Patient Health Questionnaire - 9 scale, at 3 months post-intervention;   Change from baseline in pain catastrophizing, as measured by the Pain Catastrophizing Scale, at 3 months post-intervention.;   Change from baseline in mindfulness, as measured by the Five Facet Mindfulness Questionnaire, at 3 months post-intervention.;   Change from baseline in quality of life, as measured by the Short-Form-12 Health Survey, at 3 months post-intervention.;   Change from pre-intervention in biomarkers of stress, as measured by hair cortisol levels, at 3 months post-intervention.;   Change from baseline in immune function, as measured by blood levels of interleukin-4, interleukin-6, interleukin-10, tumor necrosis factor - alpha, and C reactive protein, at 3 months post-intervention.;   Change from baseline in biomarkers of stress, as measured by telomere length, at 3 months post-intervention.;   Change from pre-intervention in neuronal health, as measured by white matter integrity, at 2 weeks post-intervention.;   Change from pre-intervention in brain areas associated with emotional regulation, as measured by blood flow in the brain seen in functional magnetic imaging, at 2 weeks post-intervention.;   Change from pre-intervention in brain structure, as measured by changes in structural volume different areas of the brain, at 2 weeks post-intervention.
7 Unknown  Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain
Condition: Pain
Interventions: Drug: Bupivacaine;   Drug: Saline
Outcome Measures: Differences in post-operative static and moving pain scores between patients randomized either to bupivacaine- (treatment) or saline- (placebo) filled, percutaneously-placed pain pump analgesic administration for post-operative pain control.;   Document long-term changes in QOL scores between patients randomized either to bupivacaine- (treatment) or saline- (placebo) filled, percutaneously-placed pain pump analgesic administration for post-operative pain control.
8 Recruiting Post-market Study of Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Improvement of Opioid-related Side Effects
Conditions: Nonmalignant Pain;   Chronic Pain;   Chronic Intractable Pain
Intervention: Device: SynchroMed Infusion System and Intrathecal Morphine Sulfate
Outcome Measures: Clinical Success;   Pain Assessment;   Opioid-Related Side Effects
9 Not yet recruiting A Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain
Conditions: Functional Abdominal Pain Syndrome;   Abdominal Pain
Interventions: Behavioral: Intervention group;   Behavioral: Active control group
Outcome Measures: Change in Pain Symptoms;   Health-related quality of life;   Pain-related coping;   Pain-related cognitions
10 Recruiting The Underlying Mechanism of Spinal Manipulative Therapy and the Effect of Pain on Physical Outcome Measures
Conditions: Low Back Pain;   Degeneration of Lumbosacral Intervertebral Disc;   Muscle Weakness;   Spine Stiffness
Interventions: Other: SMT for low back pain patients;   Other: Pain induction (optional)
Outcome Measures: Change of Modified Oswestry Low Back Pain Disability Index;   Change of 11-point Numeric Pain Rating Scale;   Change in Body Pain diagram;   Change in measurement of lumbar multifidus muscle thickness by rehabilitative ultrasound imaging;   Change of spinal stiffness testing by a mechanical indentation machine;   Electromyography of trunk muscles;   Magnetic resonance imaging of lumbar region;   Fear Avoidance Beliefs Questionnaire;   Change in Borg Category-Ratio Scale of Perceived Exertion;   Global Rating Of Change
11 Recruiting A Epidemiological Survey of Preoperative Pain Perception and Postoperative Pain in Chinese Population
Conditions: Pain;   Surgery
Intervention:
Outcome Measures: Pressure pain threshold;   Pressure pain tolerance;   PCA press frequency after operation;   Pain scores on visual analog scale after operation;   Opioid consumption dose after operation
12 Recruiting Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
Conditions: Osteoarthritis;   Rheumatoid Arthritis;   Lower Back Pain;   Joint Pain;   Muscle Pain
Intervention: Drug: Buprenorphine transdermal patch
Outcome Measures: Efficacy according to BS-11 pain score;   Secondary efficacy outcome;   Adverse events
13 Recruiting Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
Conditions: Traumatic Spinal Cord Injury;   Neuropathic Pain
Intervention: Other: blood samples
Outcome Measures: To identify candidate biomarkers for pain in the chronic SCI samples.;   To identify the temporal relationship of the development of pain and the manifestation of the biomarkers identified
14 Recruiting Characterizing the Role of Pain Sensitivity in Acute to Persistent Low Back Pain
Condition: Low Back Pain
Intervention:
Outcome Measures: Experimental Pain Threshold;   mRNA expression of pain sensitivity genes
15 Recruiting Acupuncture in Acute Nonspecific Low Back Pain
Condition: Low Back Pain
Interventions: Procedure: Acupuncture and standard treatment in general practice;   Other: Standard treatment in general practice
Outcome Measures: Median time in days to recovery of pain.;   Reduction in pain;   Global measure of improvement;   Back specific functional status;   Sick leaves;   Use of medication;   Visits at the GP;   Side effects of treatment
16 Recruiting Internet Intervention for Adolescents With Chronic Pain
Conditions: Chronic Pain;   Abdominal Pain;   Headache
Interventions: Behavioral: Online Behavioral Intervention;   Other: Education: Online Patient Education
Outcome Measures: Change in Activity Limitations from Baseline to Immediately Post-Treatment, 6-month follow-up, and 12-month follow-up;   Change in Pain from Baseline to Immediately Post-Treatment, 6-month follow-up, and 12-month follow-up;   Depression and pain-specific anxiety;   Treatment Satisfaction;   Parental Response to Pain Behavior;   Sleep Quality;   Service Use;   Miscarried Helping
17 Recruiting Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children
Conditions: Abdominal Pain;   Constipation - Functional
Interventions: Dietary Supplement: Administration of L.reuteri in children with abdominal pain;   Dietary Supplement: Administration of placebo in children with abdominal pain;   Dietary Supplement: Administration of L.reuteri in children with constipation;   Dietary Supplement: Administration of placebo in children with constipation
Outcome Measures: Intensity of abdominal pain;   Severity of chronic constipation;   Intensity of abdominal pain after treatment;   Severity of chronic constipation after treatment
18 Not yet recruiting N-of-1 Trials Using mHealth in Chronic Pain
Conditions: Musculoskeletal Pain;   Chronic Pain
Interventions: Behavioral: Trialist Intervention;   Device: smartphone
Outcome Measures: Change from baseline in pain-related interference on the Patient Reported Outcomes Measurement Information System (PROMIS) Scale at 26 weeks;   Longitudinal change from baseline in pain interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) scale at 13, 26 and 52 weeks;   Longitudinal change from baseline in pain intensity on the Patient-Reported Outcomes Measurement Information System (PROMIS) scale at 13, 26 and 52 weeks;   Longitudinal change from baseline in Health-Related Quality of Life (HRQL) on the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale at 13, 26 and 52 weeks;   Longitudinal change from baseline in participatory decision-making on the Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys at 13, 26 and 52 weeks;   Longitudinal change from baseline on the Pain Treatment Satisfaction Scale (PTSS) at 13, 26 and 52 weeks;   Longitudinal change from baseline in analgesic adherence on the Pain Medication in Primary Care Patient Questionnaire at 13, 26 and 52 weeks;   Longitudinal change from baseline in patient-provider relationship on the Trust in Physician scale at 13, 26 and 52 weeks
19 Recruiting Peri-operative Psychology and Post-operative Pain Study
Conditions: Surgery;   Pain;   Anxiety;   Depression
Intervention:
Outcome Measures: Is acute pain following orthopaedic surgery is associated with the onset of anxiety as measured using the Generalised Anxiety Disorder Questionnaire (GAD-7);   Is acute pain following orthopaedic surgery is associated with the onset of depression as measured using the Patient Health Questionnaire (PHQ-9).;   Is acute pain following orthopaedic surgery is associated with the onset of abnormal coping strategies as measured using the Pain Catastrophising Scale (PCS).;   Acute pain (NRS) will be measured on day 1 after surgery.;   Acute post operative pain (NRS) at 6 months;   Pre operative strong opioid use (binary variable);   Total opioid intake before surgery;   Somatic symptoms questionnaire (bespoke questionnaire);   Perception of care questionnaire (bespoke questionnaire);   Anxiety (GAD7) will be measured on day 1 after surgery.;   Depression (PHQ9) will be measured on day 1 after surgery.;   Catastrophising (PCS - pain catastrophising scale) will be measured on day 1;   Acute anxiety (GAD7);   Depression (PHQ9);   Quality of life (EQ5D);   Opioid use at 6 months (binary variable);   Total opioid intake on day 1 post surgery;   Length of hospital stay (days);   Catastrophising (PCS - pain catastrophising scale)
20 Recruiting The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus;   Type I Diabetes;   Type II Diabetes;   Painful Diabetic Peripheral Neuropathy;   Chronic Pain
Intervention: Behavioral: Mindfulness Based Stress Reduction
Outcome Measures: Change from baseline in pain-related disability, as measured by the Brief Pain Inventory. Pain interference scale at 3-month post-intervention.;   Change from baseline in pain severity, as measured by the Brief Pain Inventory - Pain Severity scale, at 3 months post-intervention;   Change from baseline in mood states, as measured by the Profile of Mood States scale, at 3 months post-intervention.;   Overall change in status from baseline, as measured by Patient Global Impression of Change scale, at 3 months post-intervention.;   Change from baseline in stress, as measured by the Perceived Stress Scale, at 3 months post-intervention.;   Change from baseline in depressive symptoms, as measured by the Patient Health Questionnaire - 9 scale, at 3 months post-intervention;   Change from baseline in pain catastrophizing, as measured by the Pain Catastrophizing Scale, at 3 months post-intervention.;   Change from baseline in mindfulness, as measured by the Five Facet Mindfulness Questionnaire, at 3 months post-intervention.;   Change from baseline in quality of life, as measured by the Short-Form-12 Health Survey, at 3 months post-intervention.;   Change from baseline in quality of life, as measured by the Neuropathy-Specific Quality of Life Questionnaire (NeuroQOL).;   Change from baseline in quality of health and life, as measured by the The Summary of Diabetes Self-Care Activities (SDSCA).;   Change from baseline in adverse reactions as a result of their glycemic control, as measured by the Blood Sugar Reactions Questionnaire.;   Change from pre-intervention in biomarkers of stress, as measured by hair cortisol levels, at 3 months post-intervention.;   Change from baseline in glycemic control, as measured by blood levels of Hemoglobin A1c.